ZFP36L2 and neoplasm: Since a substantial fraction of mutations were frameshifts (Figure 5A), the detected mutations and SVs were considered to impair the function of ZFP36L2 in most cases, suggesting ZFP36L2 as a tumor suppressor in CRC.